000			01976nam a2200205Ia 4500
003			MX-MdCICY
005			20250625124716.0
040			_cCICY
090			_aB-8239
245	1	0	_aEffects of Atovaquone and Diospyrin-Based Drugs on the Cellular ATP of Pneumocystis carinii f. sp. carinii
490	0		_vAntimicrobial Agents and Chemotherapy, 44(3), p.713-719, 2000
520	3		_aAtovaquone (also called Mepron, or 566C80)is a napthoquinone used for the treatment of infections caused by pathogens such as Plasmodium spp. and Pneumocystis carinii. The mechanism of action against the malarial parasite is the inhibition of dihydroorotate dehydrogenase (DHOD), a consequence of blocking electron transport by the drug. As an analog of ubiquinone (coenzyme Q [CoQ]), atovaquone irreversibly binds to the mitochondrial cytochrome bc1 complex; thus, electrons are not able to pass from dehydrogenase enzymes via CoQ to cytochrome c. Since DHOD is a critical enzyme in pyrimidine biosynthesis, and because the parasite cannot scavenge host pyrimidines, the drug is lethal to the organism. Oxygen consumption in P. carinii is inhibited by the drug; thus, electron transport has also been identified as the drug target in P. carinii. However, unlike Plasmodium DHOD, P. carinii DHOD is inhibited only at high atovaquone concentrations, suggesting that the organism may salvage host pyrimidines and that atovaquone exerts its primary effects on ATP biosynthesis. In the present study, the effect of atovaquone on ATP levels in P. carinii was measured directly from 1 to 6 h and then after 24, 48, and 72 h of exposure. The average 50
700	1	2	_aCushion, M.T.
700	1	2	_aCollins, M.
700	1	2	_aHazra, B.
700	1	2	_aKaneshiro, E.S.
856	4	0	_uhttps://drive.google.com/file/d/1e0c4f4TvP6m6Du_gTsn2zxaaaAh66OGn/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx
942			_2Loc _cREF1
008			250602s9999 xx |||||s2 |||| ||und|d
999			_c42545 _d42545